Oak Harbor Wealth Partners LLC Reduces Position in STERIS plc (NYSE:STE)

Oak Harbor Wealth Partners LLC lessened its stake in shares of STERIS plc (NYSE:STE) by 2.1% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 3,004 shares of the medical equipment provider’s stock after selling 64 shares during the period. Oak Harbor Wealth Partners LLC’s holdings in STERIS were worth $618,000 at the end of the most recent reporting period.

Several other large investors also recently bought and sold shares of STE. Ashton Thomas Securities LLC purchased a new stake in STERIS during the 3rd quarter worth approximately $25,000. Human Investing LLC purchased a new stake in shares of STERIS in the 4th quarter valued at $31,000. Anfield Capital Management LLC boosted its holdings in shares of STERIS by 100.0% in the 4th quarter. Anfield Capital Management LLC now owns 182 shares of the medical equipment provider’s stock valued at $37,000 after acquiring an additional 91 shares during the last quarter. Central Pacific Bank Trust Division boosted its holdings in shares of STERIS by 65.5% in the 4th quarter. Central Pacific Bank Trust Division now owns 192 shares of the medical equipment provider’s stock valued at $39,000 after acquiring an additional 76 shares during the last quarter. Finally, Manchester Capital Management LLC boosted its holdings in shares of STERIS by 182.7% in the 4th quarter. Manchester Capital Management LLC now owns 212 shares of the medical equipment provider’s stock valued at $44,000 after acquiring an additional 137 shares during the last quarter. Hedge funds and other institutional investors own 94.69% of the company’s stock.

STERIS Stock Performance

STE opened at $233.02 on Friday. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.13 and a quick ratio of 1.40. The firm has a fifty day moving average price of $216.96 and a 200 day moving average price of $222.85. STERIS plc has a 1 year low of $197.82 and a 1 year high of $248.24. The stock has a market cap of $22.89 billion, a P/E ratio of 49.47 and a beta of 0.92.

STERIS (NYSE:STE) last posted its quarterly earnings data on Wednesday, February 5th. The medical equipment provider reported $2.32 earnings per share for the quarter, missing analysts’ consensus estimates of $2.33 by ($0.01). STERIS had a return on equity of 13.91% and a net margin of 8.66%. Equities research analysts anticipate that STERIS plc will post 9.08 earnings per share for the current year.

STERIS Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, March 21st. Shareholders of record on Thursday, February 20th will be given a dividend of $0.57 per share. This represents a $2.28 dividend on an annualized basis and a yield of 0.98%. The ex-dividend date of this dividend is Thursday, February 20th. STERIS’s dividend payout ratio is presently 48.41%.

Wall Street Analysts Forecast Growth

Several research firms have recently commented on STE. Needham & Company LLC reaffirmed a “hold” rating on shares of STERIS in a report on Friday, November 8th. Piper Sandler upped their price objective on shares of STERIS from $260.00 to $265.00 and gave the company an “overweight” rating in a report on Monday, February 3rd. JMP Securities reiterated a “market outperform” rating and issued a $265.00 target price on shares of STERIS in a research note on Thursday, February 6th. Finally, Stephens reiterated an “overweight” rating and issued a $240.00 target price on shares of STERIS in a research note on Thursday, February 6th. One research analyst has rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $258.75.

STERIS Profile

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.